Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian CancerCompleted
NCT03695380Phase 1Updated Aug 14, 2023
Sponsor: Hoffmann-La Roche
OVARIAN CANCER
United States, Italy, Spain
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaUnknown
NCT03961698Phase 2Updated Aug 14, 2023
Sponsor: Infinity Pharmaceuticals, Inc.
Breast Cancer · Renal Cell Carcinoma
United States
Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain EdemaWithdrawn
NCT05399550Phase 2Updated Aug 7, 2023
Sponsor: Hoffmann-La Roche
Acute Ischemic Stroke
United States
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsTerminated
NCT04644315Phase 2Updated Aug 7, 2023
Sponsor: Hoffmann-La Roche
Neoplasms · Colorectal Neoplasms · Melanoma · Pancreatic Neoplasms
United States
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"Recruiting
NCT05919342NAUpdated Aug 4, 2023
Sponsor: NHS Greater Glasgow and Clyde
Heart Failure · Cardiovascular Diseases
United States, Canada, Denmark, Sweden, United Kingdom
A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid TumorsTerminated
NCT05129280Phase 1Updated Aug 4, 2023
Sponsor: Hoffmann-La Roche
Solid Tumors
United States, Australia, Belgium, Denmark, Spain +1 more
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompleted
NCT00079053Phase 1Updated Aug 4, 2023
Sponsor: NCIC Clinical Trials Group
Head and Neck Cancer
Canada
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following NephrectomyTerminated
NCT03024996Phase 3Updated Aug 3, 2023
Sponsor: Hoffmann-La Roche
Renal Cell Carcinoma
United States, Argentina, Australia, Austria, Belgium +23 more
Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCVCompleted
NCT03324633N/AUpdated Aug 2, 2023
Sponsor: ANRS, Emerging Infectious Diseases
HIV · Hepatitis C
A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) StudyTerminated
NCT05059080N/AUpdated Jul 28, 2023
Sponsor: Hoffmann-La Roche
COVID-19 · Long COVID
Argentina, Belgium, Brazil, Denmark, Germany +5 more
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)Completed
NCT02763579Phase 3Updated Jul 28, 2023
Sponsor: Hoffmann-La Roche
Small Cell Lung Carcinoma
United States, Australia, Austria, Brazil, Chile +16 more
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With EmicizumabRecruiting
NCT05802836N/AUpdated Jul 10, 2023
Sponsor: Christoph Königs
Severe Hemophilia A · Severe Hemophilia A With Inhibitor · Severe Hemophilia A Without Inhibitor
Germany
Alectinib in Combination With Bevacizumab in ALK Positive NSCLCCompleted
NCT03779191Phase 2Updated Jul 6, 2023
Sponsor: Instituto Nacional de Cancerologia de Mexico
ALK Gene Rearrangement Positive · Non-Squamous Non-Small Cell Neoplasm of Lung
Mexico
Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic MelanomaCompleted
NCT02663232N/AUpdated Jul 3, 2023
Sponsor: Hoffmann-La Roche
Metastatic Cancers
Spain
A Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device.Completed
NCT04751162N/AUpdated Jun 18, 2023
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer (NSCLC)
Spain
A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical ResectionTerminated
NCT02450331Phase 3Updated Jun 18, 2023
Sponsor: Hoffmann-La Roche
Carcinoma, Transitional Cell
United States, Australia, Belgium, Canada, China +19 more
Treatment With Pirfenidone for COVID-19 Related Severe ARDSCompleted
NCT04653831NAUpdated May 23, 2023
Sponsor: Soroka University Medical Center
Covid19 · ARDS
Israel
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + DocetaxelCompleted
NCT02586025Phase 3Updated May 22, 2023
Sponsor: Hoffmann-La Roche
Breast Cancer
China, South Korea, Taiwan, Thailand
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesCompleted
NCT03236857Phase 1Updated May 22, 2023
Sponsor: AbbVie
Malignancies · Acute Lymphoblastic Leukemia (ALL) · Acute Myeloid Leukemia (AML) · Non-Hodgkin's Lymphoma
United States, Australia, Canada, France, Germany +3 more
Registry Of Best Up-titration STrategies in Acute Heart FailureNot Yet Recruiting
NCT05865665N/AUpdated May 19, 2023
Sponsor: Heart Initiative
Acute Heart Failure
Fearon Algorithm in Warfarin Patient Self-ManagementCompleted
NCT03911661NAUpdated May 17, 2023
Sponsor: University of Utah
Atrial Fibrillation · Venous Thromboses · Heart Valve Diseases
United States
Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma PatientsWithdrawn
NCT03850028NAUpdated May 15, 2023
Sponsor: University Medical Center Groningen
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Netherlands
Barriers to Adherence to Recommended Follow-up in Women With a History of Gestational DiabetesCompleted
NCT01681147NAUpdated May 12, 2023
Sponsor: Joslin Diabetes Center
Gestational Diabetes Mellitus
United States
A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors.Completed
NCT04341259Phase 1Updated May 8, 2023
Sponsor: Hoffmann-La Roche
Solid Tumors
China
Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast CancerCompleted
NCT03084939Phase 3Updated May 6, 2023
Sponsor: Hoffmann-La Roche
Breast Cancer
China

Previous page Next page